| |
| |
|
| Insider
Information: |
Romano Sarah |
| Relationship: |
Chief Financial Officer |
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
41,857 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,774 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
41,857 |
|
|
| Total
Value |
$6,774 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kiora Pharmaceuticals |
KPRX |
Chief Financial Officer |
2022-02-10 |
22,746 |
2017-02-06 |
0 |
Premium* |
|
|
First Wave Biopharma Ord Shs |
FWBI |
Chief Financial Officer |
2024-04-01 |
19,111 |
2023-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FWBI |
First Wave Biopharma Ord ... |
Chief Financial Officer |
• – – |
2024-04-01 |
4 |
S |
$4.23 |
$317 |
D/D |
(75) |
19,111 |
0 |
- |
|
| FWBI |
First Wave Biopharma Ord ... |
Chief Financial Officer |
• – – |
2024-03-15 |
4 |
S |
$4.96 |
$5,555 |
D/D |
(1,120) |
19,186 |
0 |
- |
|
| FWBI |
First Wave Biopharma Ord ... |
Chief Financial Officer |
• – – |
2024-01-12 |
4 |
S |
$4.20 |
$412 |
D/D |
(98) |
20,306 |
0 |
- |
|
| FWBI |
First Wave Biopharma Ord ... |
Chief Financial Officer |
• – – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
20,404 |
0 |
- |
|
| FWBI |
First Wave Biopharma Ord ... |
Chief Financial Officer |
• – – |
2023-12-29 |
4 |
A |
$0.00 |
$0 |
D/D |
12,614 |
13,404 |
0 |
- |
|
| FWBI |
First Wave Biopharma Ord ... |
Chief Financial Officer |
• – – |
2023-10-04 |
4 |
S |
$0.29 |
$486 |
D/D |
(1,676) |
15,800 |
0 |
- |
|
| FWBI |
First Wave Biopharma Ord ... |
Chief Financial Officer |
• – – |
2023-07-03 |
4 |
S |
$1.54 |
$3,045 |
D/D |
(1,977) |
17,476 |
0 |
- |
|
| FWBI |
First Wave Biopharma Ord ... |
Chief Financial Officer |
• – – |
2023-04-03 |
4 |
S |
$2.50 |
$4,938 |
D/D |
(1,975) |
19,453 |
0 |
- |
|
| FWBI |
First Wave Biopharma Ord ... |
Chief Financial Officer |
• – – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
150,000 |
0 |
- |
|
| KPRX |
Kiora Pharmaceuticals |
Chief Financial Officer |
• – – |
2022-02-10 |
4 |
D |
$0.69 |
$75 |
D/D |
(108) |
22,746 |
0 |
- |
|
| KPRX |
Kiora Pharmaceuticals |
Chief Financial Officer |
• – – |
2022-01-05 |
4 |
D |
$1.08 |
$123 |
D/D |
(114) |
22,854 |
0 |
- |
|
| KPRX |
Kiora Pharmaceuticals |
Chief Financial Officer |
• – – |
2021-12-07 |
4 |
D |
$1.30 |
$118 |
D/D |
(91) |
22,968 |
0 |
- |
|
| KPRX |
Kiora Pharmaceuticals |
Chief Financial Officer |
• – – |
2021-11-02 |
4 |
D |
$1.98 |
$164 |
D/D |
(83) |
23,059 |
0 |
- |
|
| KPRX |
Kiora Pharmaceuticals |
Chief Financial Officer |
• – – |
2021-10-04 |
4 |
D |
$2.01 |
$167 |
D/D |
(83) |
23,142 |
0 |
- |
|
| KPRX |
Kiora Pharmaceuticals |
Chief Financial Officer |
• – – |
2021-09-02 |
4 |
D |
$1.81 |
$152 |
D/D |
(84) |
23,225 |
0 |
- |
|
| KPRX |
Kiora Pharmaceuticals |
Chief Financial Officer |
• – – |
2021-08-03 |
4 |
D |
$2.40 |
$209 |
D/D |
(87) |
23,309 |
0 |
- |
|
| KPRX |
Kiora Pharmaceuticals |
Chief Financial Officer |
• – – |
2021-07-02 |
4 |
D |
$3.70 |
$666 |
D/D |
(180) |
23,396 |
0 |
- |
|
| KPRX |
Kiora Pharmaceuticals |
Chief Financial Officer |
• – – |
2021-06-04 |
4 |
D |
$4.19 |
$754 |
D/D |
(180) |
23,576 |
0 |
- |
|
| KPRX |
Kiora Pharmaceuticals |
Chief Financial Officer |
• – – |
2021-05-04 |
4 |
D |
$4.13 |
$731 |
D/D |
(177) |
23,756 |
0 |
- |
|
| KPRX |
Kiora Pharmaceuticals |
Chief Financial Officer |
• – – |
2021-04-08 |
4 |
D |
$4.94 |
$889 |
D/D |
(180) |
23,933 |
0 |
- |
|
| KPRX |
Kiora Pharmaceuticals |
Chief Financial Officer |
• – – |
2021-03-03 |
4 |
D |
$5.46 |
$1,190 |
D/D |
(218) |
24,113 |
0 |
- |
|
| KPRX |
Kiora Pharmaceuticals |
Chief Financial Officer |
• – – |
2021-02-02 |
4 |
D |
$6.34 |
$8,128 |
D/D |
(1,282) |
24,331 |
0 |
- |
|
| KPRX |
Kiora Pharmaceuticals |
Chief Financial Officer |
• – – |
2021-01-04 |
4 |
D |
$4.85 |
$558 |
D/D |
(115) |
25,613 |
0 |
- |
|
| KPRX |
Kiora Pharmaceuticals |
Chief Financial Officer |
• – – |
2020-12-07 |
4 |
D |
$3.76 |
$342 |
D/D |
(91) |
25,728 |
0 |
- |
|
| KPRX |
Kiora Pharmaceuticals |
Chief Financial Officer |
• – – |
2020-11-02 |
4 |
D |
$3.51 |
$340 |
D/D |
(97) |
25,819 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
